Blog — Insights & Updates

Software Solutions & ServicesMay 17, 2026 5 min

Why Most AI Pilots Fail in Regulated Environments and How to Fix It

Discover why AI pilots in pharma often fail before production and how governance, workflows, and data foundations determine success.

Software Solutions & ServicesMay 13, 2026 7 min

How MedTech's AI Playbook Can Accelerate Compliant AI Adoption in Pharma

Discover how MedTech's validated AI approach can help pharma accelerate compliant AI adoption across R&D, clinical trials, and GMP operations.

Software Solutions & ServicesMay 13, 2026 3 min

AI in Life Sciences: From Hype to Compliant Reality

Discover why governance, validation, and trust, not model performance, are the real challenges for AI adoption in life sciences.

Software Solutions & ServicesMay 13, 2026 4 min

Why AI Is Too Generic for Regulatory Conversations in Life Sciences

Discover why AI governance in life sciences depends on intended use, risk context, and control frameworks rather than the AI label itself.

ToxicologyRegulatory AffairsMay 6, 2026 4 min

Bringing ERA into Practice: Key Challenges in Pharma

Discover the practical challenges of Environmental Risk Assessments (ERAs) in pharma, from toxicology input to data consistency and lifecycle management.

Regulatory AffairsApr 14, 2026 5 min

EU and UK Regulatory Submissions: Platforms, Authority Interactions and Timeline Control

Entering Europe after FDA approval? Learn how to manage EU and UK regulatory submissions, authority interactions, and submission timelines efficiently.

Regulatory AffairsClinicalApr 13, 2026 4 min

First-in-Human Operational Readiness for Emerging Biotechs: The Minimum Framework You Need

Prepare for First-in-Human trials with the right operational framework. Align safety, governance, and clinical execution to meet regulatory expectations.

Regulatory AffairsPharmacovigilanceApr 12, 2026 6 min

Operational Readiness for Europe: PV, QA and MAH Requirements Biotechs Cannot Ignore

Entering the EU market requires more than approval. Discover the pharmacovigilance, quality, and MAH requirements biotechs must prepare before European launch.

Qualification & ValidationApr 1, 2026 6 min

Utilities and Pharmaceutical Water Systems: A Hidden Compliance Risk Under Annex 1

Utilities such as pharmaceutical water systems and gases are often overlooked in Annex 1 remediation. Discover common compliance gaps and how to mitigate them.

ToxicologyQuality AssuranceApr 1, 2026 7 min

Extractables and Leachables (E&L): Reviewing the Current Regulatory Landscape

Extractables and leachables requirements are evolving with draft ICH Q3E. Learn how companies can prepare for future E&L regulatory expectations.

PharmacovigilanceMar 27, 2026 6 min

Scaling Pharmacovigilance Across Europe: Managing Local Requirements Without Losing Control

Expanding across Europe introduces complex pharmacovigilance requirements. Learn how EU PV systems can scale while integrating national roles and regulatory obligations.

PharmacovigilanceMar 25, 2026 5 min

AI in Pharmacovigilance: Efficiency Tool or Strategic Game-Changer?

AI is transforming pharmacovigilance processes from case processing and literature monitoring to signal detection. Discover how AI and NLP can enhance efficiency, compliance, and regulatory intelligence.

Regulatory AffairsMar 4, 2026 4 min

Scientific Advice for Startups: Turning the Right Questions into Regulatory Clarity

Scientific Advice is one of the few moments in early development where a biotech can test its assumptions with regulators. Learn how to structure questions, integrate CMC and clinical strategy, and leverage EMA SME support for maximum impact.